Suplementos

← vista completa

Publicado el 27 de diciembre de 2016 | http://doi.org/10.5867/medwave.2016.6823

El impacto bidireccional de dos enfermedades crónicas: insuficiencia cardíaca y diabetes mellitus

Bidirectional impact of two chronic diseases: heart failure and diabetes mellitus

José D. Tafur , Héctor O. Ventura

Abstract

Heart failure remains a significant burden to healthcare systems. Even of the advances in medical therapy, heart failure morbidity and mortality have not been significantly reduced. Diabetes mellitus has shown to be a significant risk factor for the development and prognosis of heart failure. Traditionally, these two chronic illnesses have been managed in relative isolation. Clinicians should be more cognizant of the bidirectional impact between heart failure and diabetes.

Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Autores

José D. Tafur

Departamento de Enfermedades Cardiovasculares, Instituto Cardiovascular John Ochsner, Escuela de Medicina, Universidad de Queensland, Nueva Orleans, Estados Unidos

jtafursoto@ochsner.org

Instituto Cardiovascular John Ochsner, Jefferson Highway1514, Nueva Orleans, Estados Unidos

Héctor O. Ventura

Departamento de Enfermedades Cardiovasculares, Instituto Cardiovascular John Ochsner, Escuela de Medicina, Universidad de Queensland, Nueva Orleans, Estados Unidos

Figures

Article has no figures.

Foro

No hay mensajes

Historial

Citación Tafur JD, Ventura HO. Bidirectional impact of two chronic diseases: heart failure and diabetes mellitus. Medwave 2016;16(Suppl4):e6823 doi: 10.5867/medwave.2016.6823

Envío 01/01/1970

Aceptación 01/01/1970

Publicación 27/12/2016

Métricas

Vistas en HTML

150

Descargas en PDF

15

Total

165

% Descargas en PDF

10%

Ver detalle

Notas

Keywords

heart failure, diabetes mellitus, mortality, cardiovascular diseases

Referencias

  1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1;127(1):e6-e245. | CrossRef | PubMed
  2. Kociol RD, Hammill BG, Fonarow GC, Klaskala W, Mills RM, Hernandez AF, et al. Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries. Am Heart J. 2010 Nov;160(5):885-92. | CrossRef | PubMed
  3. Giamouzis G, Kalogeropoulos A, Georgiopoulou V, Laskar S, Smith AL, Dunbar S, et al. Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions. J Card Fail. 2011 Jan;17(1):54-75. | CrossRef | PubMed
  4. Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Li Y, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA. 2014 Sep 24;312(12):1218-26. | CrossRef | PubMed
  5. Centers for Disease Control and Prevention. Diabetes Home. cdc.gov [on line]. | Link
  6. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979 May 11;241(19):2035-8. | PubMed
  7. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB. The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004 Aug;27(8):1879-84. | PubMed
  8. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol. 2000 May;35(6):1628-37. | PubMed
  9. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care.2001 Sep;24(9):1614-9. | PubMed
  10. Aronow WS, Ahn C. Incidence of heart failure in 2,737 older persons with and without diabetes mellitus. Chest. 1999 Mar;115(3):867-8. | PubMed
  11. Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr. Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care. 2004 Mar;27(3):699-703. | PubMed
  12. Tenenbaum A, Motro M, Fisman EZ, Leor J, Boyko V, Mandelzweig L, Behar S. Status of glucose metabolism in patients with heart failure secondary to coronary artery disease. Am J Cardiol. 2002 Sep 1;90(5):529-32. | PubMed
  13. Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson AM, Rosengren A. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet. 2011 Jul 9;378(9786):140-6. | CrossRef | PubMed
  14. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, et al. Glycemic control and heart failure among adult patients with diabetes. Circulation. 2001 Jun 5;103(22):2668-73. | PubMed
  15. Baliga V, Sapsford R. Review article: Diabetes mellitus and heart failure--an overview of epidemiology and management. Diab Vasc Dis Res. 2009 Jul;6(3):164-71. | CrossRef | PubMed
  16. Doehner W, Rauchhaus M, Ponikowski P, Godsland IF, von Haehling S, Okonko DO, et al. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol. 2005 Sep 20;46(6):1019-26. | PubMed
  17. Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif JC; Studies Of Left Ventricular Dysfunction. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation. 2003 Mar 11;107(9):1291-6. | PubMed
  18. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303-10. | PubMed
  19. Shindler DM, Kostis JB, Yusuf S, Quinones MA, Pitt B, Stewart D, et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol. 1996 May 1;77(11):1017-20. | PubMed
  20. Dei Cas A, Khan SS, Butler J, Mentz RJ, Bonow RO, Avogaro A, et al. Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure. JACC Heart Fail. 2015 Feb;3(2):136-45. | CrossRef | PubMed
  21. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006 Jul 20;355(3):251-9. | PubMed
  22. Sarma S, Mentz RJ, Kwasny MJ, Fought AJ, Huffman M, Subacius H, et al. Association between diabetes mellitus and post-discharge outcomes in patients hospitalized with heart failure: findings from the EVEREST trial. Eur J Heart Fail. 2013 Feb;15(2):194-202. | CrossRef | PubMed
  23. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006 Nov;27(22):2725-36. | PubMed
  24. Greenberg BH, Abraham WT, Albert NM, Chiswell K, Clare R, Stough WG, et al. Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure(OPTIMIZE-HF). Am Heart J. 2007 Aug;154(2):277.e1-8. | PubMed
  25. Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, et al. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation. 2006 May 9;113(18):2201-10. | PubMed
  26. Das SR, Drazner MH, Yancy CW, Stevenson LW, Gersh BJ, Dries DL. Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction(SOLVD) Prevention trial. Am Heart J. 2004 Nov;148(5):883-8. | PubMed
  27. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993 Jul;88(1):107-15. | PubMed
  28. MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme. Eur Heart J. 2008 Jun;29(11):1377-85. | CrossRef | PubMed
  29. Aguilar D, Bozkurt B, Ramasubbu K, Deswal A. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol. 2009 Jul 28;54(5):422-8. | CrossRef | PubMed